Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. (manokatra rohy)

CRASH-3 Trial Collaborators

Loharanon-kevitra‎: Lancet 2019;394(10210):1713-23.

Rakitra‎: PubMed 31623894

DOI‎: 10.1016/S0140-6736(19)32233-0

https://www.ncbi.nlm.nih.gov/pubmed/31623894 (manokatra rohy)

Alternatives to allogeneic platelet transfusion. (manokatra rohy)

Desborough MJ, Smethurst PA, Estcourt LJ, Stanworth SJ.

Loharanon-kevitra‎: Br J Haematol 2016;175(3):381-92.

Rakitra‎: PubMed 27650431

DOI‎: 10.1111/bjh.14338

https://www.ncbi.nlm.nih.gov/pubmed/27650431 (manokatra rohy)

Tranexamic acid: less bleeding and less thrombosis? (manokatra rohy)

Godier A, Roberts I, Hunt BJ.

Loharanon-kevitra‎: Crit Care 2012;16(3):135.

Rakitra‎: PubMed 22748073

DOI‎: 10.1186/cc11374

https://www.ncbi.nlm.nih.gov/pubmed/22748073 (manokatra rohy)

Tranexamic acid for reducing mortality in emergency and urgent surgery. (manokatra rohy)

Perel P, Ker K, Morales Uribe CH, Roberts I

Loharanon-kevitra‎: Cochrane Database Syst Rev 2013;(1):CD010245.

Rakitra‎: PubMed 23440847

DOI‎: 10.1002/14651858.CD010245.pub2

https://www.ncbi.nlm.nih.gov/pubmed/23440847 (manokatra rohy)

The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. (manokatra rohy)

Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, Dewan Y, Gando S, Guyatt G, Hunt BJ, Morales C, Perel P, Prieto-Merino D, Woolley T; CRASH-2 collaborators.

Loharanon-kevitra‎: Lancet 2011;377(9771):1096-101, 1101.e1-2.

Rakitra‎: PubMed 21439633

DOI‎: 10.1016/S0140-6736(11)60278-X

https://www.ncbi.nlm.nih.gov/pubmed/21439633 (manokatra rohy)

Antifibrinolytic drugs for acute traumatic injury. (manokatra rohy)

Roberts I, Shakur H, Ker K, Coats T; CRASH‐2 Trial collaborators.

Loharanon-kevitra‎: Cochrane Database Syst Rev 2011;(1):CD004896.

Rakitra‎: PubMed 21249666

DOI‎: 10.1002/14651858.CD004896.pub3

https://www.ncbi.nlm.nih.gov/pubmed/21249666 (manokatra rohy)

Use of tranexamic acid to reduce bleeding in burns surgery. (manokatra rohy)

Tang YM, Chapman TW, Brooks P

Loharanon-kevitra‎: J Plast Reconstr Aesthet Surg 2012;65(5):684-6.

Rakitra‎: PubMed 21983540

DOI‎: 10.1016/j.bjps.2011.09.028

https://www.ncbi.nlm.nih.gov/pubmed/21983540 (manokatra rohy)

Tranexamic acid reduced blood transfusions in acute burn surgery: a retrospective case-controlled trial. (manokatra rohy)

Tapking C, Hundeshagen G, Kirchner M, Fischer S, Kneser U, Bliesener B

Loharanon-kevitra‎: Burns. 2022;48(3):522-28.

Rakitra‎: PubMed 35339324

DOI‎: 10.1016/j.burns.2022.03.002

https://pubmed.ncbi.nlm.nih.gov/35339324/ (manokatra rohy)

Salvage use of activated recombinant factor VII in the management of refractory bleeding following cardiac surgery. (manokatra rohy)

Barua A, Rao VP, Ramesh B, Barua B, El-Shafei H.

Loharanon-kevitra‎: J Blood Med 2011;2:131-4.

Rakitra‎: PubMed 22287872

DOI‎: 10.2147/JBM.S21609

https://www.ncbi.nlm.nih.gov/pubmed/22287872 (manokatra rohy)

The treatment of bleeding is to stop the bleeding! Treatment of trauma-related hemorrhage. (manokatra rohy)

Boffard KD, Choong PI, Kluger Y, Riou B, Rizoli SB, Rossaint R, Warren B; NovoSeven Trauma Study Group.

Loharanon-kevitra‎: Transfusion 2009;49 Suppl 5:240S-7S.

Rakitra‎: PubMed 19954486

DOI‎: 10.1111/j.1537-2995.2008.01987.x

https://www.ncbi.nlm.nih.gov/pubmed/19954486 (manokatra rohy)

The early use of fibrinogen, prothrombin complex concentrate, and recombinant-activated factor VIIa in massive bleeding. (manokatra rohy)

Fries D

Loharanon-kevitra‎: Transfusion 2013;53 Suppl 1:91S-5S.

Rakitra‎: PubMed 23301979

DOI‎: 10.1111/trf.12041

https://www.ncbi.nlm.nih.gov/pubmed/23301979 (manokatra rohy)

A Jehovah's Witness with complex abdominal trauma and coagulopathy: use of factor VII and a review of the literature. (manokatra rohy)

Haan J, Scalea T

Loharanon-kevitra‎: Am Surg 2005;71(5):414-5.

Rakitra‎: PubMed 15986972

https://www.ncbi.nlm.nih.gov/pubmed/15986972 (manokatra rohy)

Results of the control trial: efficacy and safety of recombinant activated factor VII in the management of refractory traumatic hemorrhage. (manokatra rohy)

Hauser CJ, Boffard K, Dutton R, Bernard GR, Croce MA, Holcomb JB, Leppaniemi A, Parr M, Vincent JL, Tortella BJ, Dimsits J, Bouillon B; CONTROL Study Group.

Loharanon-kevitra‎: J Trauma 2010;69(3):489-500.

Rakitra‎: PubMed 20838118

DOI‎: 10.1097/TA.0b013e3181edf36e

https://www.ncbi.nlm.nih.gov/pubmed/20838118 (manokatra rohy)

Use of recombinant activated factor VII in patients without hemophilia: a meta-analysis of randomized control trials. (manokatra rohy)

Hsia CC, Chin-Yee IH, McAlister VC.

Loharanon-kevitra‎: Ann Surg 2008;248(1):61-8.

Rakitra‎: PubMed 18580208

DOI‎: 10.1097/SLA.0b013e318176c4ec

https://www.ncbi.nlm.nih.gov/pubmed/18580208 (manokatra rohy)

Rescue treatment with recombinant factor VIIa is effective in patients with life-threatening bleedings secondary to major wound excision: a report of four cases. (manokatra rohy)

Johansson PI, Eriksen K, Alsbjørn B

Loharanon-kevitra‎: J Trauma 2006;61(4):1016-8.

Rakitra‎: PubMed 17033583

DOI‎: 10.1097/01.ta.0000239261.48022.f1

https://www.ncbi.nlm.nih.gov/pubmed/17033583 (manokatra rohy)

Use of recombinant activated factor VII in Jehovah's Witness patients with critical bleeding. (manokatra rohy)

Kandane-Rathnayake RK, Isbister JP, Zatta AJ, Aoki NJ, Cameron P, Phillips LE; Australian and New Zealand Haemostasis Registry Steering Committee

Loharanon-kevitra‎: ANZ J Surg 2013;83(3):155-60.

Rakitra‎: PubMed 23035873

DOI‎: 10.1111/j.1445-2197.2012.06285.x

https://www.ncbi.nlm.nih.gov/pubmed/23035873 (manokatra rohy)

Recombinant factor VIIa in trauma patients with the 'triad of death.' (manokatra rohy)

Mitra B, Cameron PA, Parr MJ, Phillips L.

Loharanon-kevitra‎: Injury 2012;43(9):1409-14.

Rakitra‎: PubMed 21345431

DOI‎: 10.1016/j.injury.2011.01.033

https://www.ncbi.nlm.nih.gov/pubmed/21345431 (manokatra rohy)

Low-dose recombinant factor VIIa for trauma patients with coagulopathy. (manokatra rohy)

Stein DM, Dutton RP, Hess JR, Scalea TM.

Loharanon-kevitra‎: Injury 2008;39(9):1054-61.

Rakitra‎: PubMed 18656871

DOI‎: 10.1016/j.injury.2008.03.032

https://www.ncbi.nlm.nih.gov/pubmed/18656871 (manokatra rohy)

Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant factor VIIa (Novoseven®). (manokatra rohy)

Tanaka KA, Waly AA, Cooper WA, Levy JH.

Loharanon-kevitra‎: Anesthesiology 2003;98(6):1513-5.

Rakitra‎: PubMed 12766668

https://www.ncbi.nlm.nih.gov/pubmed/12766668 (manokatra rohy)

Alternatives to allogeneic platelet transfusion. (manokatra rohy)

Desborough MJ, Smethurst PA, Estcourt LJ, Stanworth SJ.

Loharanon-kevitra‎: Br J Haematol 2016;175(3):381-92.

Rakitra‎: PubMed 27650431

DOI‎: 10.1111/bjh.14338

https://www.ncbi.nlm.nih.gov/pubmed/27650431 (manokatra rohy)

The early use of fibrinogen, prothrombin complex concentrate, and recombinant-activated factor VIIa in massive bleeding. (manokatra rohy)

Fries D

Loharanon-kevitra‎: Transfusion 2013;53 Suppl 1:91S-5S.

Rakitra‎: PubMed 23301979

DOI‎: 10.1111/trf.12041

https://www.ncbi.nlm.nih.gov/pubmed/23301979 (manokatra rohy)

Plasma fibrinogen level on admission to the intensive care unit is a powerful predictor of postoperative bleeding after cardiac surgery with cardiopulmonary bypass. (manokatra rohy)

Kindo M, Hoang Minh T, Gerelli S, Perrier S, Meyer N, Schaeffer M, Bentz J, Announe T, Mommerot A, Collange O, Pottecher J, Cristinar M, Thiranos JC, Gros H, Mertes PM, Billaud P, Mazzucotelli JP

Loharanon-kevitra‎: Thromb Res 2014;134(2):360-8.

Rakitra‎: PubMed 24857189

DOI‎: 10.1016/j.thromres.2014.05.008

https://www.ncbi.nlm.nih.gov/pubmed/24857189 (manokatra rohy)

Combination of recombinant factor VIIa and fibrinogen corrects clot formation in primary immune thrombocytopenia at very low platelet counts. (manokatra rohy)

Larsen OH, Stentoft J, Radia D, Ingerslev J, Sørensen B

Loharanon-kevitra‎: Br J Haematol 2013;160(2):228-36.

Rakitra‎: PubMed 23151086

DOI‎: 10.1111/bjh.12118

https://www.ncbi.nlm.nih.gov/pubmed/23151086 (manokatra rohy)

Strategies to reduce the use of blood products: a European perspective. (manokatra rohy)

Theusinger OM, Felix C, Spahn DR.

Loharanon-kevitra‎: Curr Opin Anaesthesiol 2012;25(1):59-65.

Rakitra‎: PubMed 22113184

DOI‎: 10.1097/ACO.0b013e32834dec98

https://www.ncbi.nlm.nih.gov/pubmed/22113184 (manokatra rohy)

Desmopressin reduces transfusion needs after surgery: a meta-analysis of randomized clinical trials. (manokatra rohy)

Crescenzi G, Landoni G, Biondi-Zoccai G, Pappalardo F, Nuzzi M, Bignami E, Fochi O, Maj G, Calabrò MG, Ranucci M, Zangrillo A

Loharanon-kevitra‎: Anesthesiology 2008;109(6):1063-76.

Rakitra‎: PubMed 19034103

DOI‎: 10.1097/ALN.0b013e31818db18b

https://www.ncbi.nlm.nih.gov/pubmed/19034103 (manokatra rohy)

Alternatives to allogeneic platelet transfusion. (manokatra rohy)

Desborough MJ, Smethurst PA, Estcourt LJ, Stanworth SJ.

Loharanon-kevitra‎: Br J Haematol 2016;175(3):381-92.

Rakitra‎: PubMed 27650431

DOI‎: 10.1111/bjh.14338

https://www.ncbi.nlm.nih.gov/pubmed/27650431 (manokatra rohy)

Desmopressin in treatment of haematological disorders and in prevention of surgical bleeding. (manokatra rohy)

Svensson PJ, Bergqvist PB, Juul KV, Berntorp E

Loharanon-kevitra‎: Blood Rev 2014;28(3):95-102.

Rakitra‎: PubMed 24703870

DOI‎: 10.1016/j.blre.2014.03.001

https://www.ncbi.nlm.nih.gov/pubmed/24703870 (manokatra rohy)

Coagulopathy caused by vitamin K deficiency in critically ill, hospitalized patients. (manokatra rohy)

Alperin JB

Loharanon-kevitra‎: JAMA 1987;258(14):1916-9.

Rakitra‎: PubMed 3656602

DOI‎: 10.1001/jama.1987.03400140078028

https://www.ncbi.nlm.nih.gov/pubmed/3656602 (manokatra rohy)

Vitamin K deficiency and D-dimer levels in the intensive care unit: a prospective cohort study. (manokatra rohy)

Crowther MA, McDonald E, Johnston M, Cook D

Loharanon-kevitra‎: Blood Coagul Fibrinolysis 2002;13(1):49-52.

Rakitra‎: PubMed 11994567

DOI‎: 10.1097/00001721-200201000-00007

https://www.ncbi.nlm.nih.gov/pubmed/11994567 (manokatra rohy)

The use of fibrin sealant in burn operations. (manokatra rohy)

Foster K

Loharanon-kevitra‎: Surgery 2007;142(4 Suppl):S50-4.

Rakitra‎: PubMed 18019939

DOI‎: 10.1016/j.surg.2007.06.026

https://www.ncbi.nlm.nih.gov/pubmed/18019939 (manokatra rohy)

Use of fibrin sealant in thermal injury. (manokatra rohy)

McGill V, Kowal-Vern A, Lee M, Greenhalgh D, Gomperts E, Bray G, Gamelli R

Loharanon-kevitra‎: J Burn Care Rehabil 1997;18(5):429-34.

Rakitra‎: PubMed 9313125

DOI‎: 10.1097/00004630-199709000-00011

https://www.ncbi.nlm.nih.gov/pubmed/9313125 (manokatra rohy)

Perioperative treatment algorithm for bleeding burn patients reduces allogeneic blood product requirements. (manokatra rohy)

Schaden E, Kimberger O, Kraincuk P, Baron DM, Metnitz PG, Kozek-Langenecker S

Loharanon-kevitra‎: Br J Anaesth 2012;109(3):376-81.

Rakitra‎: PubMed 22719014

DOI‎: 10.1093/bja/aes186

https://www.ncbi.nlm.nih.gov/pubmed/22719014 (manokatra rohy)

Transfusion in trauma: why and how should we change our current practice? (manokatra rohy)

Theusinger OM, Spahn DR, Ganter MT.

Loharanon-kevitra‎: Curr Opin Anaesthesiol 2009;22(2):305-12.

Rakitra‎: PubMed 19390257

DOI‎: 10.1097/ACO.0b013e3283212c7c

https://www.ncbi.nlm.nih.gov/pubmed/19390257 (manokatra rohy)

Viscoelastic point-of-care testing to assist with the diagnosis, management and monitoring of haemostasis: a systematic review and cost-effectiveness analysis. (manokatra rohy)

Whiting P, Al M, Westwood M, Ramos IC, Ryder S, Armstrong N, Misso K, Ross J, Severens J, Kleijnen J

Loharanon-kevitra‎: Health Technol Assess 2015;19(58):1-228.

Rakitra‎: PubMed 26215747

DOI‎: 10.3310/hta19580

https://www.ncbi.nlm.nih.gov/pubmed/26215747 (manokatra rohy)